TWST
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Equity perpetual — synthetic exposure to a stock without owning the share. Hyperliquid orchestrates funding to keep mark close to the underlying. Trades 24/7 unlike the underlying.
Mark Price
$116.04
24h Change
+3.77%
Funding (8h)
+0.0097%
Open Interest
518
24h Volume
$0.03M
Oracle Price
$116.04
Mark − Oracle
+0.0321%
Prev Day Close
$111.82
As of (UTC)
2026-11-19 10:14:29
Daily candles — last 45 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| NVDA | $153.51 | -4.82% |
| SKHX | $891.82 | +2.73% |
| SOXL | $53.63 | +0.99% |
| SNDK | $807.55 | -2.59% |
| ANT | $104.41 | +5.78% |
News headlines Yahoo Finance, 1h cache
-
Twist Bioscience (TWST) Posted Higher Revenue And A Narrower Loss, Is It Still 31% Undervalued?
2026-11-19 07:09 · Yahoo
-
Twist Bioscience Corporation Q4 2026 Earnings Call Summary
2026-11-12 22:15 · Yahoo
-
This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock
2026-11-12 21:16 · Yahoo
-
Twist Bioscience Q4 Earnings Call Highlights
2026-11-12 21:14 · Yahoo
-
Twist Bioscience: 3 Key Takeaways for Long-Term Investors
2026-11-12 21:09 · Yahoo
-
Twist Bioscience earnings analysis: questions answered and next catalysts
2026-11-12 20:59 · Yahoo
-
Twist Bioscience (TWST) Q4 2026 Earnings Call Transcript
2026-11-12 19:45 · Yahoo
-
Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3
2026-11-12 15:07 · Yahoo
-
Twist Bioscience: Fiscal Q4 Earnings Snapshot
2026-11-12 13:40 · Yahoo
-
Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates
2026-11-12 13:35 · Yahoo